Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Human Immunome Project (HIP) is a global scientific initiative dedicated to decoding the human immune system to improve health for all. By leveraging high-throughput immune monitoring and advanced artificial intelligence, the project aims to create a comprehensive map of the human immunome and develop predictive models of immune response. These tools are designed to accelerate the development of vaccines, diagnostics, and therapies across a wide range of diseases, including cancer, infectious diseases, and autoimmune disorders. HIP operates through a network of global study sites and collaborations with academic, industrial, and government partners to generate the world's largest and most diverse immunological dataset.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HIP.